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Abstract Operative management of patients presenting renal cell carcinoma’s (RCC) with
right atrial tumor thrombus extension is a technical challenge. It requires the use of cardiopul-
monary bypass (CPB). The aim of this study was to report our early experience and to describe
a simplified CPB technique.
5 consecutive patients underwent surgical resection by a joint cardiovascular and urological
team. The ascending aorta was canulated. The venous drainage was achieved using a proximal
canula inserted in the superior vena cava and a distal canula inserted in the IVC below the re-
nal veins. Right atrium thrombus extension was extracted under normothermic CPB without
cross clamping or cardioplegic arrest. A cavotomy was performed at the ostium of the renal
vein and an endoluminal occlusion catheter was introduced. The thrombectomy and the rad-
ical nephrectomy were then performed. The occurrence of gaseous or tumor embolism, oper-
ative time, perioperative bleeding, and post-operative complications were assessed.
Mean patients age was 62.9 years. Atrial and caval thrombectomy were achieved success-
fully in all patients. Mean operative time was 206 min. Mean CPB time was 62 min. Mean hos-
pital stay was 18.8 days. One death occurred, due to respiratory failure. An asymptomatic
early thrombosis of the IVC was diagnosed by CT scan in 1 patient. The four remaining patients
were alive 6 months after the surgical procedure.
Minimally invasive CPB technique can be used to treat intra atrial thrombus tumor extension
arising from renal cell carcinoma. It can be performed safely with acceptable complications rate.
ª 2007 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
* Corresponding author. Tel.: þ33 611 831 821.
E-mail address: t-modine@chru-lille.fr (T. Modine).
1743-9191/$ - see front matter ª 2007 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.ijsu.2007.01.009
306 T. Modine et al.Introduction
Renal cell carcinoma (RCC) extends into the inferior vena
cava (IVC) as a tumor thrombus in 4 to 10% of cases.1,2 The
presence of a tumor thrombus in the IVC associated with
renal carcinoma does not modify survival when total exci-
sion of the thrombus is performed and in the absence of
nodal or visceral metastases.3,4 When not treated, poor sur-
vival rates have been reported.5
Early experiences using different techniques evolved to
date with the aim to reduce per operative morbidity. Freed
and Gliedman reported the use of a balloon catheter inserted
in the vana cava, and Foster et al. reported the use of caval-
atrial shunt to extract tumor thrombus with success.6,7 The
surgical management of renal tumors with thrombi in the
IVC has therefore become the gold standard treatment,
with reported perioperative mortality rate from 2.7 to
13%.2,8 Survival at 5 years for patients operated without pre-
operative metastases varies between 30 and 72%.2,8,9,10 The
short and mid-term risks if no treatment is performed are
massive pulmonary embolism, total obstruction of the tri-
cuspid valve, and liver failure as a result of the Budd-Chiari
syndrome. The level of tumoral extension is based on radio-
logical examination and trans-esophageal echocardiography
(TEE). When the thrombus extends into the right atrium
(level IV) cardiopulmonary bypass (CPB) is usually required.
The usual approach to perform thrombus excision is CPB
using deep hypothermic circulatory arrest. CPB improves
surgical visibility and allows complete tumor excision, but
is associated with higher overall blood loss, greater coagu-
lopathy, longer operative times with significant increase in
morbidity and mortality.11,12 To our knowledge the use of
moderate hypothermic CPB without cardioplegic myocardial
arrest and without aortic cross clamping on a routine basis
was not reported in the literature.
We report our early experience of level (IV) IVC
thrombus extraction using a simplified CPB approach.
Materials and methods
5 consecutive patients underwent surgery for RCC and
tumor thrombus extension into the right atrium. The
clinical and histological characteristics are listed in Table 1.
Table 1 Clinical and histological data
Variables
Number of patients 5
Male/female 2/3
Age average (range) 62,9 ans (37 to 79 years)
BMI (range) 25.51 Kg/m2
(21.2 to 33.3 Kg/m2)
Left/right kidney 3/2
Thrombus level IV 5 cases
Fuhrman grade
average (range)
3.4 (3 to 4)




Preoperative metastases 1 casePreoperative workup
The staging evaluation included chest, abdomen and pelvis
CT scan, abdominal ultrasound with color-Doppler, and
Magnetic Resonance Angiography (MRA). The MRA localized
the thrombus according to the suprahepatic veins and the
caval atrial junction. It also evaluated thrombus adhesion
to the vein wall. The position of the upper extremity of the
tumor thrombus was defined in accordance with the 4 levels
described by Neves and Zincke13 (level IVZ thrombus
located in the right atrium). Locoregional and metastatic
extension were evaluated in all cases by brain and chest
CT-scan, bone scan and hepatic ultrasound.
Surgical techniques
TEE was performed at the beginning of the surgical pro-
cedure in all patients to confirm the level of the upper
extremity of the thrombus. TEE was continued throughout
the operation to detect air or tumor embolisms, to localize
the occlusive balloon in the IVC, and to check complete
extraction of the thrombus. In all patients median sternot-
omy-laparotomy was performed. The IVC was exposed at
the level of the renal veins and in the infra-hepatic
segment. The liver was not mobilized. After systemic
heparinisation (300 UI/KG), ascending aorta was cannu-
lated. An angled venous cannula was placed in the superior
vena cava (SVC), and a second angled cannula was placed
above the IVC bifurcation below the renal veins. Moderate
hypothermia (33 C) CPB was initiated without cross clamp-
ing neither cardioplegic cardiac arrest. Pump flow rate was
2.4 l/min/m2. The SVC was occluded with a Rummel tourni-
quet proximally to the cannula. A longitudinal right atriot-
omy was performed allowing the introduction of an index
finger to push the thrombus into the supra hepatic IVC un-
der TEE control. Intra pericardial IVC was then clamped for
a short time, using a tourniquet. Atrial closure was
achieved and the patient weaned from CPB. The renal ar-
tery was ligated. Infra-renal IVC and contralateral renal
vein were clamped using a tourniquet. The patient was
placed in the Trendelenburg position to decrease the risk
of air embolism. A short cavotomy was performed at the os-
tium of the renal vein. A balloon catheter (venous catheter,
size 8/22F, 80 cm long, maximum volume maximum 43 cc,
Syntel, Applied Medical, Nieuwegein, NL) was introduced
through the cavotomy and was inflated above the thrombus
using physiological saline solution, thus performing endolu-
minal occlusion of the IVC. Intrapericardial IVC was then
unclamped to minimize hepatic congestion. The thrombus
was removed en bloc through a large, longitudinal antero-
lateral cavotomy, either by direct extraction or by stripping
with a second occlusion balloon. A lateral cavectomy
around the ostium of the renal vein was performed in all
cases (Fig. 1A,B). A segmental cavectomy was performed
if (macroscopic or MRA) the IVC wall was invaded by the tu-
mor. In this setting, a 19 mm diameter expanded polytetra-
fluoroethylene (PTFE) graft prosthesis was implanted; the
contralateral renal vein was anastomosed laterally to the
graft. Extended nephrectomy was then performed. When
the lumen of the vena cava presented a normal diameter,
the cavectomy was closed with a non-absorbable 5.0


























Figure 1 A: operative technique before tumor thrombus extraction, RCC: renal cell carcinoma; T: tumor thrombus; RV: renal
vein; RA: renal artery; SVC : superior vena cava; IVC : inferior vena cava. B: operative technique after tumor thrombus stripping,
RCC: renal cell carcinoma; T: tumor thrombus; RV: renal vein; RA: renal artery; SVC : superior vena cava; IVC : inferior vena cava;
BC: ballon catheter; C: cavectomy.monofilament polypropylene. Otherwise, the cavectomy
was closed on a PTFE prosthetic patch.
In the postoperative period, all patients were admitted
in the intensive care unit before being transferred to
a standard hospitalization unit. A thoraco-abdominal
angio-CT was performed before discharge to verify IVC
patency and the absence of pulmonary embolism.
Anti-coagulation with heparin and then warfarin was
initiated for a sixth month period, or for life when a
prosthetic graft had been implanted.
Follow-up (serum creatinine and thoraco-abdominal CT
scan) was performed and scheduled every 6 months.
Tumor staging
All tumors were classified according to the TNM classifica-
tions 2002.14
Assessment of the strategy
Air or tumor embolisms were assessed by TEE in the
intraoperative period and by thoracic-abdominal angio-CT
scans at discharge. The number of packed red cells trans-
fused during the perioperative period was used to quantify
bleeding. Postoperative complications were assessed.Statistical analysis
Analyses were carried out using descriptive statistics
(mean, range).
The survival was calculated from date of surgery to the
date of death or last follow.
Results
Radical nephrectomy with tumor thrombectomy was per-
formed in all patients.
Table 2 Perioperative data
Air embolism 0
Tumor migration (%) 0
Operative time 206 min (180 to 240 min)
CPB time 62 min (52 to 77 min)
Perioperative transfusions
average (range)
9,4 packed red cells (4 to 14)
Perioperative morbidity 1 respiratory failure
Hospitalization time
average (range)
18.8 (15 to 28)
Perioperative mortality 1
CPB: cardiopulmonary bypass.
308 T. Modine et al.Mean operative time was 206 min (180 to 240 min). CPB
time was 62 min (range 52 to 77 min). CT scan diagnosed an
asymptomatic early thrombosis of the IVC in 1 patient. The
perioperative data are listed in Table 2.
No tumor migration and no air embolism were depicted
by TEE during the intraoperative period. The average
number of packed red cells transfused was 9,4 packed red
cells (4 to 14). The mean intensive care unit stay was
3.6 days (range: 1 to 11 days, median 2 days), and the mean
hospital stay was 18.8 days (range: 15 to 28 days). One
death occurred in the perioperative period due to respira-
tory failure.
There were 4 renal clear cell carcinomas and one
primitive neuroectodermal tumor. Four patients had total
resection (R0) of the primary tumor, and 1 patient had
macroscopic positive tumoral margins (R2) after surgical
excision. The average Fuhrman grade was 3.4 (range 3 to 4,
median 4). The tumor invaded into the perinephric fat in all
cases. According to the TNM 2002 classification, the patho-
logic examination reported the casesas follows: pT3c (nZ 4)
and pT4 (nZ 1). Nodal invasion was diagnosed in 2 cases. 1
patient had a unique pulmonary metastasis at diagnosis; be-
cause of the tumor thrombus extension volume into the right
atrium the operative indication was maintained.
Follow-up
Four patients were still alive six months after surgery
without evidence of tumor recurrence or metastases.
Discussion
Vena caval tumor thrombus extension in a RCC is a rare
event. When present, 2% to 16% could have tumor thrombus
extension into the right atrium.3,8,13 The management of
patients with cardiac extension (level IV) must be individu-
alized. In our experience, nephrectomy with thrombectomy
of the IVC is a procedure that can be performed without
cardiopulmonary bypass (CPB), except in the setting of in-
tra-cardiac thrombi (level IV).8 CPB has been recommen-
ded, with or without hypothermia and cardiac arrest, for
levels III and IV, because it guarantees hemodynamic stabil-
ity during IVC clamping and a bloodless field.9,12,15,16 How-
ever CPB increases the operative time, cardio-respiratory
complications, postoperative bleeding, and the onset of
coagulopathies.8,17 On the other hand, digital manipulation
of the tumor to push it down from the right atrium to the
IVC without CPB protection may be hazardous. Hence, in
the absence of effective alternative treatment, complete
surgical removal of the primary tumor with its extension
along the vena cava is the only available cure option. The
results of our report suggest that a minimally invasive CPB
technique could be used to allow extensive tumor removal
in these patients.
The use of deep hypothermia CPB with circulatory arrest
in patients with tumor thrombus extending into the right
atrium has been reported.18,19 Less invasive techniques
using moderate hypothermia with ascending aorta cross
clamping and cardioplegic arrest have also been described;
in addition an occlusion balloon catheter was inserted and
advanced to the level of the supraceliac aorta and inflatedafter the heart was arrested in order to reduce vena cava
flow offering though bloodless field.20 In our experience re-
ducing vena caval flow was not necessary. The advantages
of those techniques are: a secure operation, a bloodless
field, no dissection of the retrohepatic IVC, and no occlu-
sion of the hepatic veins. Aortic clamping is however asso-
ciated with myocardial and visceral ischemia. If profound
deep hypothermic circulatory arrest (DHCA) is performed,
no aortic clamping is necessary. But the limits of DHCA
are the associated morbidities. Indeed, this technique re-
quires prolonged CBP for rewarming. It is also associated
with increased mortality rate, neurologic complications
and extensive bleeding due to platelets distortion and
tumor cells autotransfusion.21,22 Transient neurological
deficits (delirium, cognitive impairment and stroke) are
observed in 4% to 25% of patients.22,23
In our experience, moderate hypothermia CPB (33 C),
without aortic cross clamping nor cardioplegic cardiac ar-
rest was performed. This technique does not require any
clamping of neither the abdominal aorta nor the hepatic
veins. Stewart et al. reported their experience in which
cardiac arrest was not used. Nevertheless, the investigators
reported the use of vena cava interruption and satisfactory
visualization despite blood loss from the hepatic veins
which we did not observe.24 Thus our approach is safe,
easy to set up and simple to use. It maintains peripheral
perfusion and avoids the major inconvenients related to
CPB listed above in the previous reports.
Liver mobilization and transdiaphragmatic approach was
not necessary in our experience to perform safely (under
TEE monitoring) a complete caval thrombectomy. This
approach therefore reduces the risk of per operative
embolism. Tomita et al., using intraoperative TEE monitor-
ing, reported an increase risk of embolism migration during
liver mobilization.25 A complete caval thrombectomy was
performed successfully in all patients. In all cases, the
tumors were slightly friable allowing en bloc extraction.
This technique did not lead to any major complications
and was controlled by TEE monitoring. It also allowed per-
forming a segmental resection and reconstruction of the
IVC in cases of adherent thrombi. It can be recommended
as first choice technique for renal cell carcinomas with
atrial thrombus. However these tumors could be volumi-
nous and adherent. In that case our technique could be
unadapted. In our experience this was not observed.
Intra and perioperative parameters (embolism, bleeding,
transfusion.), in our series, compare favorably with other
reported series.8,17,26 In our series, CPB time was short, as
well as supra hepatic IVC clamping, thus avoiding hepatic
congestion which was not encountered. However, if the IVC
clamping has to be prolonged, a Pringle maneuver could be
achieved. Two-dimensional intraoperative TEE is a non-inva-
sive technique providing to both surgeon and anesthetist sig-
nificant informations.27,28 It confirms the exact position of
the thrombus accordingly to the preoperative workup. In ad-
dition it provides informations regarding retrohepatic IVC pa-
rietal invasion. In our study, therewas no difference between
the pre- and per operative position of the thrombi. All the tu-
mors treated were not adherent and did not invade the IVC
wall. The TEE probe was introduced shortly after the anes-
thetic induction and left in place throughout the procedure
in order to detect any tumor or air embolisms, localize the
Surgical treatment of renal cell carcinoma with right atrial thrombus 309endoluminal occlusive balloon in the free IVC above the
thrombus, and verify that the thrombus has been completely
excised. An additional advantage of TEE is its accuracy for an-
esthetic monitoring; it can replace a Swan-Ganz pulmonary
arterial catheter, monitor the ventricular function and the
mobility of the cardiac wall and septum, and study the car-
diac valves. In our experience, TEE was always used. We
believe it has advantages at every stage of the procedure.
The CPB approach described in this paper offers several
advantages. First, cerebral perfusion is maintained through
out the procedure. The morbidity related to DHCA and
aortic cross clamping is avoided. Complete resection of the
tumor was always performed, without tumor or air embo-
lism, and minimum blood loss. Hemodynamic stability and
avoiding vital organ ischemia were always achieved during
the procedure.
Conclusion
A simplified CPB technique with neither hypothermic
circulatory arrest nor cardioplegic cardiac arrest can be
performed in the surgical treatment of intra atrial throm-
bus tumor extension arising from renal cell carcinoma. It
can be performed safely, effectively and can result in
acceptable complications rate. This technique can be
recommended as first choice technique for renal cell
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